Crescent Biopharma (CBIO) Income Statement (2013 - 2026)
Income Statement report data from Mar 31, 2013 to Mar 31, 2026 for Crescent Biopharma (CBIO).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Revenue | 1.04M | - | - | - | - | - | - | - | - | 10K | - | - | - | - | - | 80K | - | 20K (-77.78%) | 90K | - | 1.06M (+562.50%) | 160K (-84.00%) | 1.00M | - | 9.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | 20K | - | - | 70K | - | 20M | - | - | 15M | - | 80K (+60.00%) | 50K (-16.67%) | 60K (-98.43%) | 3.81M |
Operating Expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Research And Development | 18M | - | 20M (+68.46%) | 12M (+13.64%) | 11M (+4521.74%) | 230K (-86.63%) | 1.72M (-72.66%) | 6.29M (+4.31%) | 6.03M (+13.99%) | 5.29M (0.00%) | 5.29M (+29.98%) | 4.07M (-24.91%) | 5.42M (-7.98%) | 5.89M (+19.72%) | 4.92M (-38.27%) | 7.97M (-16.98%) | 9.60M (-25.58%) | 13M (-2.86%) | 13M (+30.58%) | 10M (-8.79%) | 11M (-4.86%) | 12M (+9.84%) | 11M (+8.11%) | 9.87M (-22.10%) | 13M (+10.46%) | 11M (+7.00%) | 11M (-17.98%) | 13M (+11.05%) | 12M (+0.09%) | 12M (+20.86%) | 9.73M (+4.62%) | 9.30M (0.00%) | 9.30M (+38.39%) | 6.72M (+16.26%) | 5.78M (+1.05%) | 5.72M (-2.72%) | 5.88M (-2.97%) | 6.06M (+2.36%) | 5.92M (+2.42%) | 5.78M (+4.71%) | 5.52M (-20.69%) | 6.96M (+38.10%) | 5.04M (-35.71%) | 7.84M (+50.48%) | 5.21M (+3.17%) | 5.05M (-5.78%) | 5.36M (+38.14%) | 3.88M (+24.36%) | 3.12M (+5.76%) | 2.95M (+2.43%) | 2.88M (+5.11%) | 2.74M |
Selling General And Administrative | 7.87M | - | 5.54M (-38.10%) | 8.95M (+148.61%) | 3.60M (-29.13%) | 5.08M (+26.68%) | 4.01M (-1.47%) | 4.07M (-20.04%) | 5.09M (+18.10%) | 4.31M (-4.65%) | 4.52M (-7.00%) | 4.86M (-11.96%) | 5.52M (+16.70%) | 4.73M (+23.18%) | 3.84M (-29.54%) | 5.45M (+7.71%) | 5.06M (+11.21%) | 4.55M (+9.90%) | 4.14M (-2.36%) | 4.24M (+1.19%) | 4.19M (+4.49%) | 4.01M (-1.23%) | 4.06M (-4.02%) | 4.23M (-4.73%) | 4.44M (+14.73%) | 3.87M (+14.50%) | 3.38M (-9.87%) | 3.75M (+11.61%) | 3.36M (+14.68%) | 2.93M (+5.02%) | 2.79M (-2.11%) | 2.85M (0.00%) | 2.85M (+1.06%) | 2.82M (+17.50%) | 2.40M (-4.76%) | 2.52M (+20.57%) | 2.09M (-9.13%) | 2.30M (+16.16%) | 1.98M (-14.29%) | 2.31M (+12.14%) | 2.06M (+5.10%) | 1.96M (-7.98%) | 2.13M (+17.68%) | 1.81M (-4.74%) | 1.90M (+15.15%) | 1.65M (+2.48%) | 1.61M (+31.97%) | 1.22M (+48.78%) | 820K (+2.50%) | 800K (+19.40%) | 670K (+9.84%) | 610K |
Operating Expenses | 26M | - | 26M (+23.11%) | 21M (+47.89%) | 14M (+94.00%) | 7.33M (-34.73%) | 11M (+8.40%) | 10M (-6.83%) | 11M (+15.83%) | 9.60M (-2.14%) | 9.81M (+9.85%) | 8.93M (-18.37%) | 11M (+3.01%) | 11M (+21.09%) | 8.77M (-34.70%) | 13M (-8.39%) | 15M (-15.94%) | 17M (+0.11%) | 17M (+20.97%) | 14M (-6.13%) | 15M (-2.48%) | 16M (+6.79%) | 15M (+4.39%) | 14M (-17.53%) | 17M (+11.54%) | 15M (+8.72%) | 14M (-16.11%) | 17M (+11.17%) | 15M (+3.00%) | 15M (+17.33%) | 13M (+3.05%) | 12M (0.00%) | 12M (+27.36%) | 9.54M (+16.63%) | 8.18M (-0.73%) | 8.24M (+3.39%) | 7.97M (-4.67%) | 8.36M (+5.69%) | 7.91M (-2.22%) | 8.09M (+6.73%) | 7.58M (-15.02%) | 8.92M (+24.41%) | 7.17M (-25.70%) | 9.65M (+35.72%) | 7.11M (+6.12%) | 6.70M (-3.74%) | 6.96M (+36.20%) | 5.11M (+29.70%) | 3.94M (+5.07%) | 3.75M (+5.63%) | 3.55M (+5.97%) | 3.35M |
Depreciation And Amortization | 60K | - | - | - | - | 20K | - | - | 10K (-50.00%) | 20K (-50.00%) | 40K (0.00%) | 40K (0.00%) | 40K (-20.00%) | 50K (0.00%) | 50K (0.00%) | 50K (-16.67%) | 60K (0.00%) | 60K (-14.29%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (+40.00%) | 50K (0.00%) | 50K (0.00%) | 50K (0.00%) | 50K (0.00%) | 50K (0.00%) | 50K (0.00%) | 50K (0.00%) | 50K (+25.00%) | 40K (0.00%) | 40K (0.00%) | 40K (+33.33%) | 30K (-25.00%) | 40K (+33.33%) | 30K (0.00%) | 30K (0.00%) | 30K |
Operating Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Income | -24.73M | - | -25.88M (+23.06%) | -21.03M (+47.89%) | -14.22M (+94.00%) | -7.33M (-34.73%) | -11.23M (+8.40%) | -10.36M (-6.83%) | -11.12M (+15.95%) | -9.59M (-2.24%) | -9.81M (+9.85%) | -8.93M (-18.37%) | -10.94M (+3.01%) | -10.62M (+21.09%) | -8.77M (-34.31%) | -13.35M (-8.94%) | -14.66M (-15.89%) | -17.43M (+0.52%) | -17.34M (+20.42%) | -14.40M (+0.84%) | -14.28M (-8.29%) | -15.57M (+13.40%) | -13.73M (-2.69%) | -14.11M (+73.98%) | -8.11M (-47.13%) | -15.34M (+8.72%) | -14.11M (-16.11%) | -16.82M (+11.17%) | -15.13M (+3.00%) | -14.69M (+17.33%) | -12.52M (+3.05%) | -12.15M (0.00%) | -12.15M (+27.36%) | -9.54M (+16.63%) | -8.18M (-0.73%) | -8.24M (+3.39%) | -7.97M (-4.67%) | -8.36M (+5.96%) | -7.89M (-2.47%) | -8.09M (+6.73%) | -7.58M (-14.74%) | -8.89M (+23.99%) | -7.17M | 10M | -7.11M (+6.12%) | -6.70M | 8.06M | -5.11M (+32.04%) | -3.87M (+4.59%) | -3.70M (+5.71%) | -3.50M | 460K |
Ebit | -24.73M (+6.14%) | -23.30M (-9.97%) | -25.88M (+23.06%) | -21.03M (+47.89%) | -14.22M (+94.00%) | -7.33M (-34.73%) | -11.23M (+8.40%) | -10.36M (-6.83%) | -11.12M (+15.95%) | -9.59M (-2.24%) | -9.81M (+9.85%) | -8.93M (-18.37%) | -10.94M (+3.01%) | -10.62M (+21.09%) | -8.77M (-34.31%) | -13.35M (-8.94%) | -14.66M (-15.89%) | -17.43M (+0.52%) | -17.34M (+20.42%) | -14.40M (+0.84%) | -14.28M (-8.29%) | -15.57M (+13.40%) | -13.73M (-2.69%) | -14.11M (+73.98%) | -8.11M (-47.13%) | -15.34M (+8.72%) | -14.11M (-16.11%) | -16.82M (+11.17%) | -15.13M (+3.00%) | -14.69M (+17.33%) | -12.52M (+3.05%) | -12.15M (0.00%) | -12.15M (+27.36%) | -9.54M (+16.63%) | -8.18M (-0.73%) | -8.24M (+3.39%) | -7.97M (-4.67%) | -8.36M (+5.96%) | -7.89M (-2.47%) | -8.09M (+6.73%) | -7.58M (-14.74%) | -8.89M (+23.99%) | -7.17M | 10M | -7.11M (+6.12%) | -6.70M | 8.06M | -5.11M (+32.04%) | -3.87M (+4.59%) | -3.70M (+5.71%) | -3.50M | 460K |
EBITDA | -24.66M (+5.84%) | -23.30M (-5.32%) | -24.61M (+18.77%) | -20.72M (+45.71%) | -14.22M (+87.85%) | -7.57M (-32.59%) | -11.23M (+11.19%) | -10.10M (-9.01%) | -11.10M (+15.99%) | -9.57M (-2.05%) | -9.77M (+9.90%) | -8.89M (-18.44%) | -10.90M (+3.02%) | -10.58M (+21.33%) | -8.72M (-34.44%) | -13.30M (-8.90%) | -14.60M (-15.90%) | -17.36M (+0.52%) | -17.27M (+20.43%) | -14.34M (+0.91%) | -14.21M (-8.32%) | -15.50M (+13.47%) | -13.66M (-2.71%) | -14.04M (+74.63%) | -8.04M (-47.35%) | -15.27M (+8.84%) | -14.03M (-16.19%) | -16.74M (+11.16%) | -15.06M (+3.01%) | -14.62M (+17.43%) | -12.45M (+3.06%) | -12.08M (0.00%) | -12.08M (+27.56%) | -9.47M (+16.77%) | -8.11M (-0.73%) | -8.17M (+3.16%) | -7.92M (-4.69%) | -8.31M (+5.99%) | -7.84M (-2.61%) | -8.05M (+6.91%) | -7.53M (-14.82%) | -8.84M (+24.16%) | -7.12M | 10M | -7.07M (+6.16%) | -6.66M | 8.10M | -5.07M (+32.38%) | -3.83M (+4.36%) | -3.67M (+6.07%) | -3.46M | 490K |
Other Income / Expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense | - | - | - | 1.07M (-3.60%) | 1.11M (+30.59%) | 850K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 1.45M | - | 1.28M | -760.00K (-17.39%) | -920.00K | 2.16M | - | - | - | 2.38M (+290.16%) | 610K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 940K (+8.05%) | 870K (+141.67%) | 360K (-44.62%) | 650K (+182.61%) | 230K (+130.00%) | 100K (+150.00%) | 40K (-60.00%) | 100K (+233.33%) | 30K (+50.00%) | 20K (0.00%) | 20K (0.00%) | 20K | - | - | - | - | - | - | - | - | - | - |
Net Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | -17.87M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.22M (-55.09%) | -7.17M | 10M | - | -6.69M | 8.07M | - | 7.20M | -3.70M (+5.71%) | -3.50M | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -80.00K | 80K | - | - | - | - | - |
Net Income From Continuing Operations | -23.28M (-0.09%) | -23.30M (-5.32%) | -24.61M (+12.94%) | -21.79M (+43.83%) | -15.15M | 13M | -9.82M (-2.77%) | -10.10M (-5.96%) | -10.74M (+18.28%) | -9.08M (-1.30%) | -9.20M (+11.38%) | -8.26M (-20.27%) | -10.36M (+1.17%) | -10.24M (+20.19%) | -8.52M (-35.80%) | -13.27M (-9.42%) | -14.65M (-15.90%) | -17.42M (+0.52%) | -17.33M (+20.35%) | -14.40M (+0.91%) | -14.27M (-8.29%) | -15.56M (+13.41%) | -13.72M (-2.56%) | -14.08M (+83.81%) | -7.66M (-48.00%) | -14.73M (+11.17%) | -13.25M (-16.30%) | -15.83M (+12.43%) | -14.08M (+1.22%) | -13.91M (+20.12%) | -11.58M (+2.66%) | -11.28M (-2.00%) | -11.51M (+24.30%) | -9.26M (+16.48%) | -7.95M (-2.33%) | -8.14M (+2.65%) | -7.93M (-4.80%) | -8.33M (+6.11%) | -7.85M (-2.73%) | -8.07M (+6.89%) | -7.55M (-14.98%) | -8.88M (+23.85%) | -7.17M | 10M | -7.11M (+7.40%) | -6.62M | 7.99M | -5.10M (+31.78%) | -3.87M (+4.59%) | -3.70M (+5.71%) | -3.50M | 460K |
Net Income | -23.28M (-0.09%) | -23.30M (-5.32%) | -24.61M (+12.94%) | -21.79M (+43.83%) | -15.15M | 13M | -9.82M (-2.77%) | -10.10M (-5.96%) | -10.74M (+18.28%) | -9.08M (-1.30%) | -9.20M (+11.38%) | -8.26M (-20.27%) | -10.36M (+1.17%) | -10.24M (+20.19%) | -8.52M (-35.80%) | -13.27M (-9.42%) | -14.65M (-15.90%) | -17.42M (+0.52%) | -17.33M (+20.35%) | -14.40M (+0.91%) | -14.27M (-8.29%) | -15.56M (+13.41%) | -13.72M (-2.56%) | -14.08M (+83.81%) | -7.66M (-48.00%) | -14.73M (+11.17%) | -13.25M (-16.30%) | -15.83M (+12.43%) | -14.08M (+1.22%) | -13.91M (+20.12%) | -11.58M (+2.66%) | -11.28M (-2.00%) | -11.51M (+24.30%) | -9.26M (+16.48%) | -7.95M (-2.33%) | -8.14M (+2.65%) | -7.93M (-4.80%) | -8.33M (+6.11%) | -7.85M (-2.73%) | -8.07M (+6.89%) | -7.55M (-14.98%) | -8.88M (+23.85%) | -7.17M | 10M | -7.11M (+7.40%) | -6.62M | 7.99M | -5.10M (+31.78%) | -3.87M (+4.59%) | -3.70M (+5.71%) | -3.50M | 460K |
Comprehensive Income Net Of Tax | -23.28M | - | -24.61M (+12.94%) | -21.79M (+43.83%) | -15.15M (-15.22%) | -17.87M (+579.47%) | -2.63M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |